mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.4 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |